Association of protein dose on mortality
Higher protein dose, compared to usual, was associated with higher 60-day mortality (RR 1.4, 95% CI 1.1–1.8; None of the subgroup by protein interactions were statistically significant and no subgroup had lower mortality in the higher protein group (Fig. 